Skip to main content

Infiltration of Peripheral IV Therapy

0
Pipeline Programs
1
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

IvWatch
IvWatchVA - Newport News
7 programs
The ivWatch Model 400N/A1 trial
ivWatch Model 400N/A1 trial
ivWatch Model 400N/A1 trial
ivWatch Model 400N/A1 trial
ivWatch Model 400 with Milky Way SensorN/A1 trial
+2 more programs
Active Trials
NCT02123745Completed71Est. Feb 2014
NCT02553421Completed243Est. Jul 2016
NCT07228416Not Yet Recruiting25Est. Jan 2026
+4 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
IvWatchivWatch Model 400 with Milky Way Sensor
IvWatchivWatch Model 400
IvWatchivWatch Model 400 with SmartTouch and fiber optic sensor
IvWatchivWatch Model 400 with SmartTouch Sensor
IvWatchivWatch Model 400
IvWatchThe ivWatch Model 400
IvWatchivWatch Model 400

Clinical Trials (7)

Total enrollment: 554 patients across 7 trials

NCT07311733IvWatchivWatch Model 400 with Milky Way Sensor

Milky Way Sensor: Device Validation for Infiltrated Tissues

Start: Jan 2026Est. completion: Feb 202628 patients
N/ANot Yet Recruiting
NCT07228416IvWatchivWatch Model 400

Milky Way Sensor Motion Validation

Start: Dec 2025Est. completion: Jan 202625 patients
N/ANot Yet Recruiting
NCT04065373IvWatchivWatch Model 400 with SmartTouch and fiber optic sensor

ivWatch SmartTouch Sensor: Device Validation for Non-Infiltrated Tissues

Start: Apr 2019Est. completion: Jun 201945 patients
N/ACompleted
NCT04064229IvWatchivWatch Model 400 with SmartTouch Sensor

ivWatch Sensor: Device Validation for Infiltrated Tissues

Start: Apr 2019Est. completion: Apr 201999 patients
N/ACompleted
NCT02553421IvWatchivWatch Model 400

Optical Detection of Intravenous Infiltration:A Pilot Study

Start: Aug 2015Est. completion: Jul 2016243 patients
N/ACompleted
NCT02123745IvWatchThe ivWatch Model 400

ivWatch Model 400: Device Validation for Infiltrated Tissues

Start: Feb 2014Est. completion: Feb 201471 patients
N/ACompleted
NCT02120443IvWatchivWatch Model 400

ivWatch Model 400: Device Validation for Non-Infiltrated Tissues

Start: Jan 2014Est. completion: Jan 201443 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.